Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4

View through CrossRef
This study intended to investigate the role of lncRNA NR2F1-AS1 in endometrial cancer (EC). The expression level of NR2F1-AS1 in tumor tissues and EC cells was measured. After sh-NR2F1-AS1 transfection, the cell viability, apoptosis, migration and invasion of EC cells were analyzed. Luciferase reporter assay was conducted to investigate the target gene of miR-363. The expression levels of PI3K/AKT/GSK-3β pathway-associated factors were assayed using western blot. NR2F1-AS1 was significantly overexpressed in EC tissues and cells. NR2F1-AS1 inhibition decreased EC cell viability, migration and invasion, while promoted cell apoptosis. miR-363 was negatively regulated by NR2F1-AS1. SOX4 was a target of miR-363. NR2F1-AS1 functioned on EC progression via PI3K/AKT/GSK-3β pathway. The results demonstrated that NR2F1-AS1 was highly expressed in EC, which involved in the proliferation and migration of EC cells through downregulation of miR-363 to target SOX4 and regulating PI3K/AKT/GSK-3β pathway.
Title: LncRNA NR2F1-AS1 is involved in the progression of endometrial cancer by sponging miR-363 to target SOX4
Description:
This study intended to investigate the role of lncRNA NR2F1-AS1 in endometrial cancer (EC).
The expression level of NR2F1-AS1 in tumor tissues and EC cells was measured.
After sh-NR2F1-AS1 transfection, the cell viability, apoptosis, migration and invasion of EC cells were analyzed.
Luciferase reporter assay was conducted to investigate the target gene of miR-363.
The expression levels of PI3K/AKT/GSK-3β pathway-associated factors were assayed using western blot.
NR2F1-AS1 was significantly overexpressed in EC tissues and cells.
NR2F1-AS1 inhibition decreased EC cell viability, migration and invasion, while promoted cell apoptosis.
miR-363 was negatively regulated by NR2F1-AS1.
SOX4 was a target of miR-363.
NR2F1-AS1 functioned on EC progression via PI3K/AKT/GSK-3β pathway.
The results demonstrated that NR2F1-AS1 was highly expressed in EC, which involved in the proliferation and migration of EC cells through downregulation of miR-363 to target SOX4 and regulating PI3K/AKT/GSK-3β pathway.

Related Results

SOX4 promotes the growth and metastasis of breast cancer
SOX4 promotes the growth and metastasis of breast cancer
Abstract Purpose Increasing evidence has shown that the transcription factor SOX4 is closely associated with the development and progression of many malignant tumors. Howe...
Lnc NR2F1-AS1 promotes breast cancer metastasis by targeting miR-25-3p/ZEB2 axis
Lnc NR2F1-AS1 promotes breast cancer metastasis by targeting miR-25-3p/ZEB2 axis
Abstract Background: Long noncoding RNAs (LncRNAs) has been demonstrated to have a considerable effect on tumor metastasis and are aberrently expressed in a variety of canc...
Abstract PD15-09: Sox4 and smarca4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in tnbc
Abstract PD15-09: Sox4 and smarca4 upregulate glycolysis-driven tumor proliferation through hexokinase 2 in tnbc
Abstract Background Triple-negative breast cancer (TNBC) accounts for nearly 1-in-4 breast cancer related deaths in the United States each year despite representing ...
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis
Background: Hepatocellular carcinoma (HCC) is one of the most deadly cancer types worldwide, and its incidence is high in China. Multiple long non-coding RNAs (lncRNAs) have been r...
Involvement of FAM170B-AS1 , hsa-miR-1202 , and hsa-miR-146a-5p in breast cancer
Involvement of FAM170B-AS1 , hsa-miR-1202 , and hsa-miR-146a-5p in breast cancer
BACKGROUND: FAM170B-AS1 is usually expressed low in all organs except for testicular tissues. No study was performed to explore its role in breast cancer (BC). ...
Inhibition of Sox4 Increases the Sensitivity of Drug-resistant Melanoma Cells to Cisplatin through the P38 Signaling Pathway
Inhibition of Sox4 Increases the Sensitivity of Drug-resistant Melanoma Cells to Cisplatin through the P38 Signaling Pathway
Background: SRY-Box Transcription Factor 4 (Sox4) has been found to be overexpressed in a number of malignancies and is linked to medication resistance. The underlying mechanism of...

Back to Top